Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):10.1097/QAI.0b013e3182a7ee2e. doi: 10.1097/QAI.0b013e3182a7ee2e

Table 1.

Participant characteristics, stratified by HCV and HIV infection status

HCV/HIV Infection Status
Uninfected
(n=166)
HCV-monoinfected
(n=703)
HCV/HIV-coinfected
(n=322)
p-valuea
Age, mean [SD] 42.9 [7.9] 47.6 [8.3] 46.8 [6.4] <0.001
Female sex 40.4 33.7 36.0 0.26
African Americanb 89.2 84.5 93.5 <0.001
Married, ever 27.1 40.2 27.2 <0.001
Employedc 31.3 27.3 20.2 0.012
Homelessc 13.9 16.8 14.3 0.49
Cigarette usec 83.7 85.8 81.9 0.27
Alcohol use, ≥1 day/weekc 61.5 55.2 45.5 0.001
Injection drug use intensityc
  None 61.5 50.5 57.8 0.001
  <Daily 21.7 24.5 27.3
  ≥Daily 16.9 25.0 14.9
Depressive symptoms 25.9 21.6 26.5 0.17
No. of comorbiditiesd, median [IQR] 1 [0, 1] 1 [0, 2] 2 [1, 3] <0.001
  Chronic kidney disease 9.7 20.8 49.8 <0.001
  Anemia 14.5 20.2 37.0 <0.001
  Diabetes 8.4 8.7 7.1 0.73
  Hypertension 31.7 42.8 37.2 0.020
  Liver fibrosis 12.3 29.9 40.8 <0.001
  Obstructive lung disease 16.6 15.6 16.5 0.92
BMI
  <25 45.2 44.5 54.1 0.019
  25–30 26.8 33.1 27.7
  ≥30 28.0 22.3 18.2
IL−6 (pg/ml), median [IQR] 1.37 [0.90, 2.26] 1.56 [0.98, 2.78] 1.82 [1.21, 3.15] 0.002
CRP (mg/l), median [IQR] 2.13 [0.94, 5.57] 1.56 [0.53, 4.82] 1.36 [0.51, 3.88] 0.003

Abbreviations: SD = standard deviation, IQR = interquartile range, HCV = hepatitis C virus, HIV = human immunodeficiency virus, BMI = body mass index

All values given as percentages unless otherwise indicated.

a

p-values comparing determined using Fisher’s exact tests for categorical variables and analysis of variance for continuous variables (normal distribution) or Hodges-Lehmann’s tests on equality of medians for continuous variables (non-normal distribution).

b

African American race is in comparison to white/other which is 81% white, 12% other, and 7% Asian, Alaskan/Native American, and white Hispanic.

c

In prior 6 months.

d

Comorbidities include a summary score of chronic kidney disease, anemia, diabetes, hypertension, liver fibrosis, and obstructive lung disease.